Ulcerative Colitis - Page 7 
The MD Magazine Ulcerative Colitis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Gut Microbiome Changes Contribute to Inflammatory Bowel Disease
Microbial changes are a contributing factor to inflammatory bowel disease (IBD) development, according to findings published in Cellular and Molecular Gastroenterology and Hepatology.
The pharmaceutical company Shire won a patent trial concerning mesalamine (Lialda), an ulcerative colitis drug, according to a company press release.
Researchers have developed a fast, simple, and minimally invasive screening test for ulcerative colitis that uses infrared technology.
Inflammatory bowel diseases (IBD) may be countered with worm infection in the gut microbiome, according to successful mice and human studies presented in the journal Science.
Tofacitinib (Xeljans/Pfizer), an oral ulcerative colitis (UC) drug, successfully met key endpoints in two Phase III studies enrolling adult patients with moderate to severe active UC.
Previously associated primarily with assessing blood alcohol level, breath tests can now aid in accurately distinguishing irritable bowel syndrome (IBS).
Men diagnosed with multiple sclerosis often have higher blood pressure than women, in addition to higher levels of diabetes, epilepsy, depression, and anxiety.
Medical economists estimate Crohn's disease is responsible for $3.48 billion in total national costs (expected to increase to $3.72 billion in 2025).
The presence of anti-microbial antibodies that have accumulated for years before a person is diagnosed with Crohn’s disease spells complications and a difficult course of treatment.

Most Popular


$vacMongoViewPlus$ $vAR$